Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14070-5. doi: 10.1073/pnas.93.24.14070.

Abstract

By transfecting fibroblast cells with an HIV-1-MN molecular clone with a deletion of the major packaging sequence, we have developed a stable HIV-1 packaging cell line, psi 422, psi 422 cells form syncytia with CD4-positive cells, correctly express HIV-1 structural proteins, and produce a large amount of mature particles with normal reverse transcriptase activity. Yet these particles, in which RNA was not detected by reverse transcriptase-PCR, are not infectious. When stably transfected with an HIV-1-based retroviral vector, the psi 422 cell line produces virions capable of transducing CD4-positive cells with high efficiency (up to 10(5) cells per ml). The availability of this stable noninfectious HIV-1 packaging cell line capable of generating high-titer HIV-1 vectors represents a new step toward the use of an HIV-1 delivery system in gene therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • CD4 Antigens / physiology
  • Cell Line
  • DNA Primers
  • Genetic Therapy / methods
  • Genetic Vectors*
  • Giant Cells
  • HIV-1 / genetics*
  • HIV-1 / physiology
  • HIV-1 / ultrastructure
  • Humans
  • Polymerase Chain Reaction
  • Transfection / methods*
  • Viral Proteins / biosynthesis
  • Viral Proteins / isolation & purification
  • Viral Structural Proteins / biosynthesis*
  • Viral Structural Proteins / isolation & purification
  • Virion / genetics
  • Virion / pathogenicity
  • Virion / physiology

Substances

  • CD4 Antigens
  • DNA Primers
  • Viral Proteins
  • Viral Structural Proteins